BenevolentAI (OTC:BAIVF) has announced that chief technology officer James Malone will give a presentation at BioTechX Europe in Basel on Thursday, October 10 at 11:45am (CET).
The presentation, titled ‘Building Trust and Explainability in Using AI in Drug Discovery’, will highlight the company's innovative R2E (Retrieve to Explain) system.
R2E combines AI-driven information retrieval and explainable predictions to improve drug target identification.
It processes complex queries and integrates biomedical data to enhance transparency in drug discovery.
Malone will share data comparing R2E's performance with traditional methods, focusing on its success in predicting clinical trial outcomes.
His presentation follows his participation in a keynote panel at the event which featured executives from AstraZeneca, QIAGEN, Merck, and Novartis.